Evidence exhibits that insufficient or low well being literacy (LHL) ranges are considerably related to financial ramifications at the particular person, employer, and well being care system ranges. Therefore, this examine goals to estimate the financial burden of LHL amongst a culturally and linguistically numerous (CALD) group in Blacktown: a neighborhood authorities space (LGA) in Sydney, Australia.
This examine is a secondary evaluation of cross-sectional information from publicly accessible datasets, together with 2011 and 2016 census information and National Health Survey (NHS) information (2017-2018) from the Australian Bureau of Statistics (ABS), and figures on Disease Expenditure in Australia for 2015-2016 offered by the Australian Institute of Health and Welfare (AIHW).
This examine discovered that 20% of Blacktown residents reported low ranges of energetic engagement with well being care suppliers (Domain 6 of the Health Literacy Questionnaire (HLQ)), with 14% reporting a restricted understanding of the well being info required to take motion in direction of enhancing well being or making well being care choices (Domain 9 of the HLQ).
The general further/delta price (direct and oblique well being care prices) related to LHL in the Blacktown LGA was estimated to be between $11,785,528 and $15,432,239 in 2020. This is projected to extend to between $18,922,844 and $24,191,911 in 2030. Additionally, the further disability-adjusted life yr (DALY) worth in 2020, for all power ailments and age-groups-comprising the further prices incurred as a consequence of years of life misplaced (YLL) and years lived with incapacity (YLD)-was estimated at $414,231,335. The findings of our examine might allow policymakers to have a deeper understanding of the financial burden of LHL in phrases of its affect on the well being care system and the manufacturing economic system.
Roadmap for Managing SARS-CoV-2 and different Viruses in the Water Environment for Public Health
The water sector wants to deal with viral-related public well being points, as a result of water is a virus provider, which not solely spreads viruses (e.g., by way of ingesting water), but additionally offers details about the circulation of viruses in the group (e.g., by way of sewage). It has been broadly reported that waterborne viral pathogens are considerable, numerous, complicated, and threatening the public well being in each developed and growing international locations. Meanwhile, there may be nice potential for viral monitoring that may point out biosafety, remedy efficiency and group well being.
New developments in know-how have been rising to satisfy the rising challenges over the previous many years. Under the present coronavirus illness 2019 (COVID-19) pandemic brought on by extreme acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the world’s consideration is directed to the pressing must sort out the most difficult public well being points associated to waterborne viruses. Based on vital evaluation of the water viral information progresses and gaps, this text gives a roadmap for managing COVID-19 and different viruses in the water environments for guaranteeing public well being.
Strategies Used to Support Peer Provision in Mental Health: A Scoping Review
The employment of peer suppliers (individuals who draw on their lived expertise of psychological well being challenges) has grown in conjunction with the elevated acceptance of restoration as a key precept in psychological well being coverage and apply. Barriers to the integration of peer suppliers in psychological well being companies have been effectively documented.
This evaluation addresses an under-explored space by consolidating methods undertaken by psychological well being organizations for the profitable implementation of peer provision. A scoping evaluation was chosen to facilitate the fast abstract and dissemination of analysis findings which might be related to policymakers and practitioners. Peer-reviewed articles and gray literature have been sourced from three databases, key peer help web sites and a hand search of the included research.
Following screening, information have been extracted from 28 research: 25 qualitative and three combined strategies research. The information have been analyzed utilizing thematic evaluation and arranged into themes. Four themes emerged from the information.
Championing of peer provision initiatives by organizational management is central to the success and sustainability of peer provision. Leadership undergirds three methods that have been mentioned: organizational preparation, recruitment, coaching and induction, and help and improvement. When peer provision is championed by organizational management, measures may be undertaken to organize the group for peer provision; recruit, practice and induce peer suppliers efficiently into the group; and help peer suppliers on the job.
The want for well being AI ethics in medical faculty training
Health Artificial Intelligence (AI) has the potential to enhance well being care, however at the identical time, raises many moral challenges. Within the subject of well being AI ethics, the options to the questions posed by moral points equivalent to knowledgeable consent, bias, security, transparency, affected person privateness, and allocation are complicated and tough to navigate.
Lung Tissue Lysate (Normal) |
1701-04 |
ProSci |
0.1 mg |
EUR 260.7 |
Description: Lung tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol. |
Lung Tissue Lysate (Normal) |
1701-05 |
ProSci |
0.1 mg |
EUR 260.7 |
Description: Lung tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol. |
Human Adult Lung (Normal) Whole tissue lysate |
HAL-1302 |
Alpha Diagnostics |
1 mg |
EUR 628.8 |
Monkey (Cyno.) Normal Lung Whole tissue lysate |
MCL-1194 |
Alpha Diagnostics |
1 mg |
EUR 628.8 |
Monkey (Rhesus) Normal Lung Whole tissue lysate |
MRL-1305 |
Alpha Diagnostics |
1 mg |
EUR 628.8 |
Tissue Lysate (Normal) Human Heart |
GWB-54C253 |
GenWay Biotech |
0.15 mg |
Ask for price |
|
Tissue Lysate (Normal) Human Kidney |
GWB-FEAC28 |
GenWay Biotech |
0.15 mg |
Ask for price |
Human Tissue Lysate (Normal) Human Stomach |
GWB-3BB116 |
GenWay Biotech |
0.15 mg |
Ask for price |
|
Human Tissue Lysate (Normal) Human Prostate |
GWB-326D8C |
GenWay Biotech |
0.15 mg |
Ask for price |
|
Human Tissue Lysate (Normal) Human Pancreas |
GWB-8C6670 |
GenWay Biotech |
0.15 mg |
Ask for price |
cDNA - Human Adult Normal Tissue: Lung |
C1234152 |
Biochain |
40 reactions |
EUR 424 |
Human Adult Eye whole (Normal) tissue lysate |
HAL-1385 |
Alpha Diagnostics |
100 ug |
EUR 285.6 |
Human Adult Skin (Normal) Whole tissue lysate |
HAL-1376 |
Alpha Diagnostics |
1 mg |
EUR 628.8 |
Human Lung Tissue Lysate |
30R-AL006 |
Fitzgerald |
150 ug |
EUR 210 |
|
Description: Fresh tissue lysate isolated from human lung |
Human Adult Heart (Normal) Whole tissue lysate |
HAL-1301 |
Alpha Diagnostics |
1 mg |
EUR 628.8 |
Human Adult Brain (Normal) Whole tissue lysate |
HAL-1303 |
Alpha Diagnostics |
1 mg |
EUR 628.8 |
Human Adult Liver (Normal) Whole tissue lysate |
HAL-1304 |
Alpha Diagnostics |
1 mg |
EUR 628.8 |
Human Adult Ovary (Normal) Whole tissue lysate |
HAL-1316 |
Alpha Diagnostics |
1 mg |
EUR 628.8 |
Human Adult Colon (Normal) Whole tissue lysate |
HAL-1320 |
Alpha Diagnostics |
1 mg |
EUR 628.8 |
Total RNA - Human Adult Normal Tissue: Lung |
R1234152-50 |
Biochain |
50 ug |
EUR 221 |
Human Adult Kidney (Normal) Whole tissue lysate |
HAL-1305 |
Alpha Diagnostics |
1 mg |
EUR 628.8 |
Human Adult Spleen (Normal) Whole tissue lysate |
HAL-1306 |
Alpha Diagnostics |
1 mg |
EUR 628.8 |
Human Adult Breast (Normal) Whole tissue lysate |
HAL-1311 |
Alpha Diagnostics |
1 mg |
EUR 628.8 |
Human Adult Testis (Normal) Whole tissue lysate |
HAL-1313 |
Alpha Diagnostics |
1 mg |
EUR 628.8 |
Human Adult Thymus (Normal) Whole tissue lysate |
HAL-1314 |
Alpha Diagnostics |
1 mg |
EUR 628.8 |
Human Adult Tonsil (Normal) Whole tissue lysate |
HAL-1315 |
Alpha Diagnostics |
1 mg |
EUR 628.8 |
Human Adult Uterus (Normal) Whole tissue lysate |
HAL-1317 |
Alpha Diagnostics |
1 mg |
EUR 628.8 |
Human Adult Rectum (Normal) Whole tissue lysate |
HAL-1373 |
Alpha Diagnostics |
1 mg |
EUR 628.8 |
Human Adult Retina (Normal) Whole tissue lysate |
HAL-1374 |
Alpha Diagnostics |
1 mg |
EUR 628.8 |
Human Adult Bladder (Normal) Whole tissue lysate |
HAL-1310 |
Alpha Diagnostics |
1 mg |
EUR 628.8 |
Human Adult Stomach (Normal) Whole tissue lysate |
HAL-1319 |
Alpha Diagnostics |
1 mg |
EUR 628.8 |
Human Adult Thyroid (Normal) Whole tissue lysate |
HAL-1380 |
Alpha Diagnostics |
1 mg |
EUR 628.8 |
Human Normal Adrenal Gland Whole tissue lysate |
HALX-11050 |
Alpha Diagnostics |
1 mg |
EUR 927.6 |
Human Adult Pancreas (Normal) Whole tissue lysate |
HAL-1307 |
Alpha Diagnostics |
1 mg |
EUR 628.8 |
Human Adult Placenta (Normal) Whole tissue lysate |
HAL-1309 |
Alpha Diagnostics |
1 mg |
EUR 628.8 |
Human Adult Prostate (Normal) Whole tissue lysate |
HAL-1312 |
Alpha Diagnostics |
1 mg |
EUR 628.8 |
Human Adult Appendix (Normal) Whole tissue lysate |
HAL-1361 |
Alpha Diagnostics |
1 mg |
EUR 628.8 |
Human Pituitary Gland (Normal) Whole tissue lysate |
HALX-10141 |
Alpha Diagnostics |
100ug |
EUR 416.4 |
Total Protein - Human Adult Normal Tissue: Lung |
P1234152 |
Biochain |
1 mg |
EUR 216 |
Human Lung Tissue Preparation Buffer 1: Normal Lung Fibroblasts |
9-80081 |
CHI Scientific |
1 x 100 ml |
Ask for price |
Frozen Tissue Section - Human Adult Normal: Lung |
T1234152 |
Biochain |
5 slides |
EUR 377 |
Colon Tissue Lysate (Normal) |
1715-01 |
ProSci |
0.1 mg |
EUR 260.7 |
Description: Colon tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol. |
Colon Tissue Lysate (Normal) |
1715-02 |
ProSci |
0.1 mg |
EUR 260.7 |
Description: Colon tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol. |
Colon Tissue Lysate (Normal) |
1715-03 |
ProSci |
0.1 mg |
EUR 260.7 |
Description: Colon tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol. |
Colon Tissue Lysate (Normal) |
1715-04 |
ProSci |
0.1 mg |
EUR 260.7 |
Description: Colon tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol. |
Colon Tissue Lysate (Normal) |
1715-05 |
ProSci |
0.1 mg |
EUR 260.7 |
Description: Colon tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol. |
Colon Tissue Lysate (Normal) |
1715-06 |
ProSci |
0.1 mg |
EUR 260.7 |
Description: Colon tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol. |
Colon Tissue Lysate (Normal) |
1715-07 |
ProSci |
0.1 mg |
EUR 260.7 |
Description: Colon tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol. |
Colon Tissue Lysate (Normal) |
1715-08 |
ProSci |
0.1 mg |
EUR 260.7 |
Description: Colon tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol. |
Colon Tissue Lysate (Normal) |
1715-10 |
ProSci |
0.1 mg |
EUR 260.7 |
Description: Colon tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol. |
Colon Tissue Lysate (Normal) |
1715-11 |
ProSci |
0.1 mg |
EUR 260.7 |
Description: Colon tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol. |
Colon Tissue Lysate (Normal) |
1715-12 |
ProSci |
0.1 mg |
EUR 260.7 |
Description: Colon tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol. |
Colon Tissue Lysate (Normal) |
1715-13 |
ProSci |
0.1 mg |
EUR 260.7 |
Description: Colon tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol. |
Colon Tissue Lysate (Normal) |
1715-14 |
ProSci |
0.1 mg |
EUR 260.7 |
Description: Colon tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol. |
Colon Tissue Lysate (Normal) |
1715-15 |
ProSci |
0.1 mg |
EUR 260.7 |
Description: Colon tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol. |
Colon Tissue Lysate (Normal) |
1715-16 |
ProSci |
0.1 mg |
EUR 260.7 |
Description: Colon tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol. |
Colon Tissue Lysate (Normal) |
1715-17 |
ProSci |
0.1 mg |
EUR 260.7 |
Description: Colon tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol. |
Colon Tissue Lysate (Normal) |
1715-19 |
ProSci |
0.1 mg |
EUR 260.7 |
Description: Colon tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol. |
Colon Tissue Lysate (Normal) |
1715-20 |
ProSci |
0.1 mg |
EUR 260.7 |
Description: Colon tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol. |
Colon Tissue Lysate (Normal) |
1715-21 |
ProSci |
0.1 mg |
EUR 260.7 |
Description: Colon tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol. |
Colon Tissue Lysate (Normal) |
1715-22 |
ProSci |
0.1 mg |
EUR 260.7 |
Description: Colon tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol. |
Liver Tissue Lysate (Normal) |
1718-01 |
ProSci |
0.1 mg |
EUR 260.7 |
Description: Liver tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol. |
Liver Tissue Lysate (Normal) |
1718-02 |
ProSci |
0.1 mg |
EUR 260.7 |
Description: Liver tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol. |
Brain Tissue Lysate (Normal) |
1731-01 |
ProSci |
0.1 mg |
EUR 260.7 |
Description: Brain tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol. |
Brain Tissue Lysate (Normal) |
1731-02 |
ProSci |
0.1 mg |
EUR 260.7 |
Description: Brain tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol. |
Brain Tissue Lysate (Normal) |
1731-03 |
ProSci |
0.1 mg |
EUR 260.7 |
Description: Brain tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol. |
Paraffin Tissue Section - Human Adult Normal: Lung |
T2234152 |
Biochain |
5 slides |
EUR 204 |
Membrane Protein - Human Adult Normal Tissue: Lung |
P3234152 |
Biochain |
0.1 mg |
EUR 311 |
Human Adult Lymph Node (Normal) Whole tissue lysate |
HAL-1369 |
Alpha Diagnostics |
1 mg |
EUR 927.6 |
Kidney Tissue Lysate (Normal) |
1706-02 |
ProSci |
0.1 mg |
EUR 260.7 |
Description: Kidney tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol. |
Kidney Tissue Lysate (Normal) |
1706-03 |
ProSci |
0.1 mg |
EUR 260.7 |
Description: Kidney tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol. |
Kidney Tissue Lysate (Normal) |
1706-04 |
ProSci |
0.1 mg |
EUR 260.7 |
Description: Kidney tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol. |
Kidney Tissue Lysate (Normal) |
1706-05 |
ProSci |
0.1 mg |
EUR 260.7 |
Description: Kidney tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol. |
Breast Tissue Lysate (Normal) |
1710-01 |
ProSci |
0.1 mg |
EUR 260.7 |
Description: Breast tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol. |
Breast Tissue Lysate (Normal) |
1710-03 |
ProSci |
0.1 mg |
EUR 260.7 |
Description: Breast tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol. |
Breast Tissue Lysate (Normal) |
1710-04 |
ProSci |
0.1 mg |
EUR 260.7 |
Description: Breast tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol. |
Breast Tissue Lysate (Normal) |
1710-05 |
ProSci |
0.1 mg |
EUR 260.7 |
Description: Breast tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol. |
Breast Tissue Lysate (Normal) |
1710-06 |
ProSci |
0.1 mg |
EUR 260.7 |
Description: Breast tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol. |
Breast Tissue Lysate (Normal) |
1710-07 |
ProSci |
0.1 mg |
EUR 260.7 |
Description: Breast tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol. |
Breast Tissue Lysate (Normal) |
1710-08 |
ProSci |
0.1 mg |
EUR 260.7 |
Description: Breast tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol. |
Breast Tissue Lysate (Normal) |
1710-10 |
ProSci |
0.1 mg |
EUR 260.7 |
Description: Breast tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol. |
Breast Tissue Lysate (Normal) |
1710-11 |
ProSci |
0.1 mg |
EUR 260.7 |
Description: Breast tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol. |
Breast Tissue Lysate (Normal) |
1710-12 |
ProSci |
0.1 mg |
EUR 260.7 |
Description: Breast tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol. |
Cervix Tissue Lysate (Normal) |
1746-01 |
ProSci |
0.1 mg |
EUR 260.7 |
Description: Cervix tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol. |
Cervix Tissue Lysate (Normal) |
1746-02 |
ProSci |
0.1 mg |
EUR 260.7 |
Description: Cervix tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol. |
Cervix Tissue Lysate (Normal) |
1746-03 |
ProSci |
0.1 mg |
EUR 260.7 |
Description: Cervix tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol. |
Human Adult Spinal Cord (Normal) Whole tissue lysate |
HAL-1377 |
Alpha Diagnostics |
1 mg |
EUR 927.6 |
Stomach Tissue Lysate (Normal) |
1717-01 |
ProSci |
0.1 mg |
EUR 260.7 |
Description: Stomach tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol. |
Bladder Tissue Lysate (Normal) |
1721-01 |
ProSci |
0.1 mg |
EUR 260.7 |
Description: Bladder tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol. |
FFPE Total RNA - Human Adult Normal Tissue: Lung |
R2234152 |
Biochain |
1 ug |
EUR 744 |
Pancreas Tissue Lysate (Normal) |
1736-02 |
ProSci |
0.1 mg |
EUR 260.7 |
Description: Pancreas tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol. |
Pancreas Tissue Lysate (Normal) |
1736-05 |
ProSci |
0.1 mg |
EUR 260.7 |
Description: Pancreas tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol. |
Lung Tissue Slide (Normal) |
10-101-10um |
ProSci |
10 um |
EUR 241.8 |
Lung Tissue Slide (Normal) |
10-101-4um |
ProSci |
4 um |
EUR 216.6 |
Normal lung tissue array |
LC725 |
TissueArray |
each |
EUR 270 |
Description: Normal lung tissue array, 24 cases/72 cores, replacing BN04011 |
Normal lung tissue array |
LCN241 |
TissueArray |
each |
EUR 114 |
Description: Normal lung tissue array, 24 cases/24 cores |
FFPE Genomic DNA - Human Adult Normal Tissue: Lung |
D2234152 |
Biochain |
2 ug |
EUR 787 |
Human Lung Fetal Tissue Lysate |
IHULGFSTL100UG |
Innovative research |
each |
EUR 541 |
|
Description: Human Lung Fetal Tissue Lysate |
Human Adult Salivary (Normal) Gland Whole tissue lysate |
HAL-20103 |
Alpha Diagnostics |
1 mg |
EUR 927.6 |
Human Adult Small Intestine (Normal) Whole tissue lysate |
HAL-1308 |
Alpha Diagnostics |
1 mg |
EUR 628.8 |
Human Adult Skeletal Muscle (Normal) Whole tissue lysate |
HAL-1375 |
Alpha Diagnostics |
1 mg |
EUR 628.8 |
Human Lupus Lung Tissue Lysate |
IHULGLUPPTL100UG |
Innovative research |
each |
EUR 1413 |
|
Description: Human Lupus Lung Tissue Lysate |
Human Diabetes Lung Tissue Lysate |
IHULGDIBTL100UG |
Innovative research |
each |
EUR 1413 |
|
Description: Human Diabetes Lung Tissue Lysate |
Lung cancer tissue array with adjacent normal lung tissue |
LC813a |
TissueArray |
each |
EUR 270 |
Description: Lung cancer tissue array with adjacent normal lung tissue, including TNM, clinical stage and pathology grade, 78 cases/80 cores, replaced by LC813b |
Liver Tissue Lysate Normal Rabbit |
GWB-369DB5 |
GenWay Biotech |
0.15 mg |
Ask for price |
|
Lung cancer and normal lung tissue array |
LC482 |
TissueArray |
each |
EUR 198 |
Description: Lung cancer and normal lung tissue array, including TNM, clinical stage and pathology grade, 24 cases/48 cores |
Lung cancer and normal lung tissue array |
LC811a |
TissueArray |
each |
EUR 270 |
Description: Lung cancer and normal lung tissue array, including pathology grade, TNM and clinical stage, 80 cases/80 core |
cDNA - Human Adult Normal Tissue: Lung: Left Lower Lobe |
C1234155 |
Biochain |
40 reactions |
EUR 424 |
cDNA - Human Adult Normal Tissue: Lung: Left Upper Lobe |
C1234156 |
Biochain |
40 reactions |
EUR 424 |
cDNA - Rat Normal Tissue: Lung |
C1434152 |
Biochain |
40 reactions |
EUR 424 |
cDNA - Dog Normal Tissue: Lung |
C1734152 |
Biochain |
40 reactions |
EUR 424 |
Total RNA - Human Adult Normal Tissue: Lung, 0 shipping |
ATR1234152-50 |
Biochain |
50 ug |
EUR 241 |
cDNA - Human Adult Normal Tissue: Lung: Right Lower Lobe |
C1234157 |
Biochain |
40 reactions |
EUR 424 |
cDNA - Human Adult Normal Tissue: Lung: Right Upper Lobe |
C1234159 |
Biochain |
40 reactions |
EUR 424 |
cDNA - Human Adult Normal Tissue: Lung: Right Middle Lobe |
C1234158 |
Biochain |
40 reactions |
EUR 424 |
cDNA - Mouse Normal Tissue: Lung |
C1334152 |
Biochain |
40 reactions |
EUR 424 |
Normal lung tissue with liver tissue array |
LCN981 |
TissueArray |
each |
EUR 354 |
Description: Normal lung tissue with liver tissue array, 49 cases/98 cores (1.5mm) |
Human WI-38 (Lung Fibroblast, normal) lysate |
HCL-1226 |
Alpha Diagnostics |
100ug |
EUR 285.6 |
Rat Tissue Lysate Normal Eye Retina |
GWB-792900 |
GenWay Biotech |
0.15 mg |
Ask for price |
Total RNA - Human Adult Normal Tissue 5 Donor Pool: Lung |
R1234152-P |
Biochain |
50 ug |
EUR 443 |
Lung Tissue Slides, Normal Human Paraffin Sections, 5 slides/pack |
TS-H5015 |
IHC World |
- |
EUR 145 |
Total RNA - Human Adult Normal Tissue: Lung: Left Lower Lobe |
R1234155-50 |
Biochain |
50 ug |
EUR 221 |
Total RNA - Human Adult Normal Tissue: Lung: Left Upper Lobe |
R1234156-50 |
Biochain |
50 ug |
EUR 221 |
Human Liver Cirrhosis Lung Tissue Lysate |
IHULGCIRTL100UG |
Innovative research |
each |
EUR 1413 |
|
Description: Human Liver Cirrhosis Lung Tissue Lysate |
Total RNA - Human Adult Normal Tissue: Lung: Right Lower Lobe |
R1234157-50 |
Biochain |
50 ug |
EUR 221 |
Total RNA - Human Adult Normal Tissue: Lung: Right Upper Lobe |
R1234159-50 |
Biochain |
50 ug |
EUR 221 |
Lung tuberculosis tissue array with normal tissue |
LC1007 |
TissueArray |
each |
EUR 306 |
Description: Lung tuberculosis tissue array with normal tissue, 48 cases/100 cores |
Total RNA - Human Adult Normal Tissue: Lung: Right Middle Lobe |
R1234158-50 |
Biochain |
50 ug |
EUR 221 |
Total RNA - Rat Normal Tissue: Lung |
R1434152-50 |
Biochain |
50 ug |
EUR 156 |
Matched Pair - DNA - Human Primary Tumor and Normal Tissue: Lung |
D8235152-PP-10 |
Biochain |
2x10 ug |
EUR 478 |
Rat normal lung test tissue array |
TR041 |
TissueArray |
each |
EUR 48 |
Description: Rat normal lung test tissue array, 6 cases/24 cores |
Matched Pair - cDNA - Human Primary Tumor and Normal Tissue: Lung |
C8235152-PP |
Biochain |
10 reactions x2 |
EUR 583 |
Total Protein - Human Adult Normal Tissue: Lung: Left Lower Lobe |
P1234155 |
Biochain |
1 mg |
EUR 216 |
Total Protein - Human Adult Normal Tissue: Lung: Left Upper Lobe |
P1234156 |
Biochain |
1 mg |
EUR 216 |
Genomic DNA - Rat Normal Tissue: Lung |
D1434152 |
Biochain |
100 ug |
EUR 329 |
Total RNA - Mouse Normal Tissue: Lung |
R1334152-50 |
Biochain |
50 ug |
EUR 156 |
Total Protein - Human Adult Normal Tissue: Lung: Right Lower Lobe |
P1234157 |
Biochain |
1 mg |
EUR 216 |
Total Protein - Human Adult Normal Tissue: Lung: Right Upper Lobe |
P1234159 |
Biochain |
1 mg |
EUR 216 |
Lung cancer and normal tissue array |
LC722 |
TissueArray |
each |
EUR 306 |
Description: Lung cancer and normal tissue array, with TNM and grade data, 24 cases/72 cores |
Rat Tissue Lysate Kidney Medulla Normal |
GWB-F5DEBF |
GenWay Biotech |
0.15 mg |
Ask for price |
Total Protein - Human Adult Normal Tissue: Lung: Right Middle Lobe |
P1234158 |
Biochain |
1 mg |
EUR 216 |
Genomic DNA - Mouse Normal Tissue: Lung |
D1334152 |
Biochain |
100 ug |
EUR 329 |
Monkey (Cyno.) Normal Adipose tissue lysate |
MCL-1159 |
Alpha Diagnostics |
1 mg |
EUR 927.6 |
Membrane Protein - Human Adult Normal Tissue: Lung: Left Upper Lobe |
P3234156 |
Biochain |
0.1 mg |
EUR 311 |
Lung adenocarcinoma tissue array with normal lung tissue (2015 WHO classification) |
BC04119b |
TissueArray |
each |
EUR 270 |
Description: Lung adenocarcinoma tissue array with normal lung tissue (2015 WHO classification), including pathology grade, TNM and clinical stage,30 cases/40 cores, replacing BC04119a |
cDNA - Monkey (Rhesus) Normal Tissue: Lung |
C1534152 |
Biochain |
40 reactions |
EUR 481 |
Monkey (Rhesus) Normal Adipose tissue lysate |
MRL-1266 |
Alpha Diagnostics |
1 mg |
EUR 927.6 |
Total Protein - Mouse Normal Tissue: Lung |
P1334152 |
Biochain |
1 mg |
EUR 216 |
Genomic DNA - Human Adult Normal Tissue: Lung, from a single donor |
D1234152 |
Biochain |
100 ug |
EUR 329 |
Lung non-small cell carcinoma NSCLC tissue array with normal lung tissue |
LC10011b |
TissueArray |
each |
EUR 306 |
Description: Lung non-small cell carcinoma NSCLC tissue array with normal lung tissue, including TNM, clinical stage and pathology grade, 50 cases/100 cores, replacing LC10011a |
Universal Protein Lysate: Human Normal Tissues |
P4234565 |
Biochain |
4x0.5 mg |
EUR 466 |
Universal Protein Lysate: Human Normal Tissues |
P4234565-1 |
Biochain |
2x0.5 mg |
EUR 311 |
Matched Pair - Total RNA - Human Primary Tumor and Normal Tissue: Lung |
R8235152-PP-10 |
Biochain |
2x10 ug |
EUR 500 |
cDNA - Monkey (Cynomolgus) Normal Tissue: Lung |
C1534152-Cy |
Biochain |
40 reactions |
EUR 481 |
Lung cancer tissue array with normal tissue as control |
LC1021 |
TissueArray |
each |
EUR 306 |
Description: Lung cancer tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 102 cases/102 cores |
Lung cancer tissue array with normal tissue as control |
LC807b |
TissueArray |
each |
EUR 306 |
Description: Lung cancer tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, cases/ cores,replacing LC807a |
Monkey (Cyno.) Normal Skin Whole tissue lysate |
MCL-1204 |
Alpha Diagnostics |
1 mg |
EUR 927.6 |
Lung non-small cell carcinoma NSCLC tissue array with cancer adjacent lung tissue and normal lung tissue |
LC10012b |
TissueArray |
each |
EUR 306 |
Description: Lung non-small cell carcinoma NSCLC tissue array with cancer adjacent lung tissue and normal lung tissue, including TNM, clinical stage and pathology grade, 50 cases/100 cores, replaced by LC10012c |
Monkey (Cyno.) Normal Colon Whole tissue lysate |
MCL-1179 |
Alpha Diagnostics |
1 mg |
EUR 628.8 |
Monkey (Cyno.) Normal Liver Whole tissue lysate |
MCL-1191 |
Alpha Diagnostics |
1 mg |
EUR 628.8 |
Monkey (Cyno.) Normal Brain Whole tissue lysate |
MCL-1272 |
Alpha Diagnostics |
1 mg |
EUR 628.8 |
Monkey (Cyno.) Normal Breast Whole tissue lysate |
MCL-1177 |
Alpha Diagnostics |
1 mg |
EUR 927.6 |
Monkey (Cyno.) Normal Kidney Whole tissue lysate |
MCL-1190 |
Alpha Diagnostics |
1 mg |
EUR 628.8 |
Monkey (Cyno.) Normal Rectum Whole tissue lysate |
MCL-1203 |
Alpha Diagnostics |
1 mg |
EUR 927.6 |
Monkey (Cyno.) Normal Spleen Whole tissue lysate |
MCL-1209 |
Alpha Diagnostics |
1 mg |
EUR 628.8 |
Monkey (Cyno.) Normal Testis Whole tissue lysate |
MCL-1215 |
Alpha Diagnostics |
1 mg |
EUR 927.6 |
Monkey (Cyno.) Normal Thymus Whole tissue lysate |
MCL-1217 |
Alpha Diagnostics |
1 mg |
EUR 927.6 |
Monkey (Cyno.) Normal Uterus Whole tissue lysate |
MCL-1222 |
Alpha Diagnostics |
1 mg |
EUR 927.6 |
Monkey (Rhesus) Normal Skin Whole tissue lysate |
MRL-1315 |
Alpha Diagnostics |
1 mg |
EUR 927.6 |
Monkey (Cyno.) Normal Bladder Whole tissue lysate |
MCL-1162 |
Alpha Diagnostics |
1 mg |
EUR 927.6 |
Monkey (Cyno.) Normal Stomach Whole tissue lysate |
MCL-1210 |
Alpha Diagnostics |
1 mg |
EUR 628.8 |
Monkey (Cyno.) Normal Thyroid Whole tissue lysate |
MCL-1218 |
Alpha Diagnostics |
1 mg |
EUR 927.6 |
Monkey (Rhesus) Normal Brain Whole tissue lysate |
MRL-1272 |
Alpha Diagnostics |
1 mg |
EUR 628.8 |
Monkey (Rhesus) Normal Colon Whole tissue lysate |
MRL-1288 |
Alpha Diagnostics |
1 mg |
EUR 628.8 |
Monkey (Rhesus) Normal Heart Whole tissue lysate |
MRL-1299 |
Alpha Diagnostics |
1 mg |
EUR 927.6 |
Monkey (Rhesus) Normal Liver Whole tissue lysate |
MRL-1302 |
Alpha Diagnostics |
1 mg |
EUR 628.8 |
Lung small cell cancer array and normal lung tissue array |
LC10010d |
TissueArray |
each |
EUR 306 |
Description: Lung small cell cancer array and normal lung tissue array, including TNM and clinical stage, 50 cases/100 cores (1.0), replacing LC10010c |
Matched Pair (Normal and Carcinoma) Human Lung Tissue Array (5 slides/pk) |
TAS-1002 |
Alpha Diagnostics |
1 pk |
EUR 343.2 |
Human Lung Tissue Preparation Buffer 3: Normal Pulmonary Artery Fibroblasts |
9-80083 |
CHI Scientific |
1 x 100 ml |
Ask for price |
Rat Lung Tissue Preparation Buffer 1: Normal Lung Fibroblasts |
9-80271 |
CHI Scientific |
1 x 100 ml |
Ask for price |
Monkey (Cyno.) Normal Appendix Whole tissue lysate |
MCL-1161 |
Alpha Diagnostics |
1 mg |
EUR 927.6 |
The growing quantity of information, market forces, and altering panorama of well being care counsel that medical college students could also be confronted with a office in which understanding easy methods to safely and successfully work together with well being AIs shall be important. Here we argue that there’s a want to show well being AI ethics in medical faculties. Real occasions in well being AI already pose moral challenges to the medical group. We focus on key moral points requiring medical faculty training and counsel that case research based mostly on latest real-life examples are helpful instruments to show the moral points raised by well being AIs.